Cue Advisory Services’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Cue Advisory Services’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-30,178	Closed	-$1.79M	–	93
2018 Q3	$1.79M	Sell	30,178 -100	-0.3%	-$5.83K	1.08%	27
2018 Q2	$1.66M	Sell	30,278 -270	-0.9%	-$13.7K	1.01%	30
2018 Q1	$1.5M	Sell	30,548 -3,140	-9%	-$160K	0.99%	27
2017 Q4	$1.59M	Sell	33,688 -3,604	-10%	-$169K	1.04%	27
2017 Q3	$1.86M	Buy	37,292 +1,135	+3%	+$53.8K	1.29%	19
2017 Q2	$1.65M	Buy	36,157 +2,273	+7%	+$98.1K	1.19%	23
2017 Q1	$1.43M	Buy	33,884 +5,357	+19%	+$225K	1.08%	24
2016 Q4	$1.11M	Sell	28,527 -2,375	-8%	-$95.9K	0.9%	33
2016 Q3	$1.3M	Sell	30,902 -4,213	-12%	-$173K	1.09%	25
2016 Q2	$1.3M	Sell	35,115 -1,089	-3%	-$42.7K	1.11%	24
2016 Q1	$1.39M	Buy	36,204 +1,005	+3%	+$39K	1.21%	20
2015 Q4	$1.78M	Buy	35,199 +118	+0.3%	+$5.83K	1.59%	8
2015 Q3	$1.6M	Buy	35,081 +2,695	+8%	+$151K	1.67%	9
2015 Q2	$1.89M	Buy	32,386 +815	+3%	+$46.6K	1.78%	4
2015 Q1	$1.74M	Buy	31,571 +584	+2%	+$31.6K	1.75%	5
2014 Q4	$1.56M	Buy	+30,987	New	+$1.52M	1.64%	5

Other funds holding PBE

ACM

Arlington Capital Management Arlington Heights, Illinois $161M AUM 38.38% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Cue Advisory Services's PBE Position: Q4 2018 in Review

Cue Advisory Services sold out of Invesco Biotechnology & Genome ETF (PBE) in Q4 2018, closing a stake of 30,178 shares — an estimated $1.79M sold.

Cue Advisory Services first reported a position in PBE in Q4 2014 and held it in 16 quarters. The position peaked at $1.89M in Q2 2015. 71 funds tracked by Wall St. Rank hold PBE as of Q4 2018.

Cue Advisory Services reported no remaining Invesco Biotechnology & Genome ETF position as of Q4 2018 after selling out during the quarter.
Cue Advisory Services sold 30,178 Invesco Biotechnology & Genome ETF shares in Q4 2018, an estimated $1.79M.
Cue Advisory Services first reported a position in Invesco Biotechnology & Genome ETF in Q4 2014 and held it in 16 quarters.
Cue Advisory Services's Invesco Biotechnology & Genome ETF position peaked at $1.89M in Q2 2015.
71 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2018.

Based on Cue Advisory Services's 13F filing for Q4 2018.